Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Salicylates Potentiate and Broaden CRM1 Inhibitor Anti-Tumor Activity Via S-Phase Arrest and Impaired DNA-Damage Repair

Jithma P. Abeykoon, MD, Xiaosheng Wu, MD, Kevin E. Nowakowski, Surendra Dasari, PhD, Jonas Paludo, MD, S. John Weroha, Chunling Hu, PhD, Jann Sarkaria, Ann Mladek, Jessica Phillips, PhD, Andrew L. Feldman, MD, Aishwarya Ravindran, MBBS, Rebecca L. King, MD, Mary J. Stenson, Michelle Manske, MS, BS, Fergus Couch, Mrinal M. Patnaik, MDMBBS, Thomas E. Witzig, MD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-138619

Published: 2020

Journal Articles

Identification of a Novel Role for PD-1 Signaling in Promotion Tumor Proliferation in B-Cell Lymphoma

Blood (2020) 136 (Supplement 1): 10–12.

https://doi.org/10.1182/blood-2020-136550

Published: 2020

Journal Articles

The Expression of Chromosome Region Maintenance Protein 1 (CRM1) in Large Cell Lymphoma

Jithma P. Abeykoon, MD, Paul J. Hampel, MD, Rebecca L. King, MD, Adam J Wood, MD, Melissa C. Larson, MD, Kevin E. Nowakowski, Saurabh Zanwar, MDMBBS, Aishwarya Ravindran, MBBS, Matthew J. Maurer, MS, Linda Wellik, Jonas Paludo, MD, Brian K. Link, MD, James R. Cerhan, MD PhD, Xiaosheng Wu, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-138628

Published: 2020

Journal Articles

PD-1 Overexpression in Richter's Transformation (RT) and Aggressive Chronic Lymphocytic Leukemia (CLL) after Progression on Ibrutinib Increases Bcl-2 Expression Via Akt/mTOR Pathway

Sutapa Sinha, PhD, Tammy Price-Troska, BS, Shulan Tian, MS, PhD, Charla R Secreto, Xiaosheng Wu, MD, Timothy G. Call, MD, Rong He, MD, Sameer A. Parikh, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Huihuang Yan, PhD, Karen L Rech, MD, Minetta C Liu, MD, Stephen M. Ansell, MD PhD, Neil E. Kay, MD, Wei Ding, MD PhD

Blood (2018) 132 (Supplement 1): 586.

https://doi.org/10.1182/blood-2018-99-112575

Published: 2018

Journal Articles

CD147 Is a Novel Regulator of Progression and Proliferation of Multiple Myeloma Plasma Cells

Bonnie K. Arendt, Denise K. Walters, PhD, Xiaosheng Wu, MD, Renee C. Tschumper, Paul M. Huddleston, M.D., Kimberly J. Henderson, Angela Dispenzieri, MD, Diane F. Jelinek, Ph.D.

Blood (2011) 118 (21): 470.

https://doi.org/10.1182/blood.V118.21.470.470

Published: 2011

Journal Articles

Mechanisms of the Formation of Multinuclear Malignant Plasma Cells in the Novel AL/MM Human Cell Lines, ALMC-1 and ALMC-2: Implications for Tumor Cell Growth Control.

Bonnie K Arendt, Xiaosheng Wu, MD, Philip R Greipp, MD, S. Vincent Rajkumar, MD, Robert Kyle, MD, Rhett P Ketterling, MD, Ryan A Knudson, Diane F Jelinek

Blood (2008) 112 (11): 1707.

https://doi.org/10.1182/blood.V112.11.1707.1707

Published: 2008

Journal Articles

Comprehensive Analysis of BAFF Binding Receptor Profiles and Receptor Occupancy in B Cell Chronic Lymphocytic Leukemia: Identification of Discrete Phenotypic Subgroups.

Renee C. Tschumper, BS, Jaime R. Darce, PhD, Xiaosheng Wu, MD, Stephen A. Mihalcik, BS, Diane F. Jelinek, PhD

Blood (2007) 110 (11): 1135.

https://doi.org/10.1182/blood.V110.11.1135.1135

Published: 2007

NARROW

Salicylates Potentiate and Broaden CRM1 Inhibitor Anti-Tumor Activity Via S-Phase Arrest and Impaired DNA-Damage Repair

Identification of a Novel Role for PD-1 Signaling in Promotion Tumor Proliferation in B-Cell Lymphoma

The Expression of Chromosome Region Maintenance Protein 1 (CRM1) in Large Cell Lymphoma

PD-1 Overexpression in Richter's Transformation (RT) and Aggressive Chronic Lymphocytic Leukemia (CLL) after Progression on Ibrutinib Increases Bcl-2 Expression Via Akt/mTOR Pathway

CD147 Is a Novel Regulator of Progression and Proliferation of Multiple Myeloma Plasma Cells

Mechanisms of the Formation of Multinuclear Malignant Plasma Cells in the Novel AL/MM Human Cell Lines, ALMC-1 and ALMC-2: Implications for Tumor Cell Growth Control.

Comprehensive Analysis of BAFF Binding Receptor Profiles and Receptor Occupancy in B Cell Chronic Lymphocytic Leukemia: Identification of Discrete Phenotypic Subgroups.

Email alerts

ASH Publications

American Society of Hematology

Salicylates Potentiate and Broaden CRM1 Inhibitor Anti-Tumor Activity Via S-Phase Arrest and Impaired DNA-Damage Repair

Identification of a Novel Role for PD-1 Signaling in Promotion Tumor Proliferation in B-Cell Lymphoma

The Expression of Chromosome Region Maintenance Protein 1 (CRM1) in Large Cell Lymphoma

PD-1 Overexpression in Richter's Transformation (RT) and Aggressive Chronic Lymphocytic Leukemia (CLL) after Progression on Ibrutinib Increases Bcl-2 Expression Via Akt/mTOR Pathway

CD147 Is a Novel Regulator of Progression and Proliferation of Multiple Myeloma Plasma Cells

Mechanisms of the Formation of Multinuclear Malignant Plasma Cells in the Novel AL/MM Human Cell Lines, ALMC-1 and ALMC-2: Implications for Tumor Cell Growth Control.

Comprehensive Analysis of BAFF Binding Receptor Profiles and Receptor Occupancy in B Cell Chronic Lymphocytic Leukemia: Identification of Discrete Phenotypic Subgroups.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only